CORRECTION: Avanos Medical Q4 Adj. EPS $0.36 Misses $0.37 Estimate, Sales $173.30M Beat $170.43M Estimate
Portfolio Pulse from Benzinga Newsdesk
Avanos Medical (NYSE:AVNS) reported Q4 adjusted EPS of $0.36, missing the consensus estimate of $0.37 by 2.7%. Year-over-year, earnings decreased by 20% from $0.45 per share. Q4 sales were $173.30M, exceeding estimates by 1.68% but showing a 4.57% decrease from the previous year's $181.60M.
February 21, 2024 | 12:01 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Avanos Medical reported a Q4 adjusted EPS of $0.36, missing estimates by 2.7%, and a 20% decrease YOY. Sales of $173.30M exceeded estimates but fell 4.57% YOY.
The miss in EPS expectations and the year-over-year decrease in both earnings and sales suggest a negative short-term impact on AVNS's stock price. Although sales exceeded estimates, the overall decline in financial performance is likely to concern investors.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100